Financhill
Back

Roku, Inc. Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Sell
47

ROKU
Roku, Inc.

Last Price:
$110.74
Seasonality Move:
-3.9%
Buy
63

GPCR
Structure Therapeutics, Inc.

Last Price:
$69.61
Seasonality Move:
-34.19%
Sell
47
Roku, Inc. (ROKU) is a Sell

Is Roku, Inc. a Buy, Sell or Hold?

  • The current Roku, Inc. [ROKU] share price is $110.35. The Score for ROKU is 47, which is 6% below its historic median score of 50, and infers higher risk than normal.
  • ROKU is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
63
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Structure Therapeutics, Inc. [GPCR] share price is $71.29. The Score for GPCR is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.
  • GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

ROKU Stock Price Chart

What is Roku, Inc.'s stock price today?

  • The Roku, Inc. share price today is $110.35
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ROKU is experiencing buying pressure, which is a positive indicator for future bullish movement.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

  • The Structure Therapeutics, Inc. share price today is $71.29
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing buying pressure, which is a positive indicator for future bullish movement.

ROKU Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 27.08 Buy
Relative Strength Index (14 RSI): 62.76 Buy
Chaikin Money Flow: 1677298 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (94.35 - 108.05) Buy
Bollinger Bands (100): (91.26 - 104.42) Buy

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 8.5 Buy
Relative Strength Index (14 RSI): 72.85 Buy
Chaikin Money Flow: 1903413 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (33.41 - 65.27) Buy
Bollinger Bands (100): (17 - 45.24) Buy

ROKU Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 109.39 Buy
20-day SMA: 103.19 Buy
50-day SMA: 100.83 Buy
200-day SMA: 86.37 Buy
8-day EMA: 78.48 Buy
20-day EMA: 43.15 Buy
50-day EMA: 19.86 Buy
200-day EMA: 5.34 Buy

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 64.43 Buy
20-day SMA: 52.92 Buy
50-day SMA: 40.28 Buy
200-day SMA: 26.09 Buy
8-day EMA: 64 Buy
20-day EMA: 55.88 Buy
50-day EMA: 44.22 Buy
200-day EMA: 31.26 Buy

Roku, Inc. Earnings Growth & ROKU Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.41 per share, and an increase next year of $0.83 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.48 per share, and a decrease next year of $0.10 per share.

Roku, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):